Tenofovir Expanded Access
Tenofovir DF, Gilead Sciences' experimental nucleotide analogue, is now available through a small expanded access program.
To qualify, you must:
To register in the program, your doctor should call 800-445-3235.
The dose is 300mg taken once a day. Tenofovir DF is expected to be considered for FDA approval this summer. Hopefully, the program criteria will be expanded before then.
This article was provided by AIDS Community Research Initiative of America. It is a part of the publication CRIA Update. Visit ACRIA's website to find out more about their activities, publications and services.